Quetiapine immediate release v. placebo for schizophrenia: systematic review, meta-analysis and reappraisal.

Immediate-release (IR) quetiapine has been used to treat schizophrenia since 1997, although all the principal placebo-controlled trials have >50% missing outcome data. New studies with relatively lower rates of participant withdrawal have since been published.